PerkinElmer Announces Financial Results for the Second Quarter of 2018

Published: Aug 01, 2018

Aug. 1, 2018 20:15 UTC
  • GAAP revenue growth of 29% to $703.4 million; Core Organic revenue growth of 10%
  • GAAP earnings per share from continuing operations of $0.58; Adjusted earnings per share of $0.91, an increase of 36%
  • GAAP operating income margin of 12.5%; Adjusted operating income margin from continuing operations of 19.7%, an increase of 180 basis points
  • Raises FY18 Guidance

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the second quarter ended July 1, 2018.

The Company reported GAAP earnings per share from continuing operations of $0.58, as compared to GAAP earnings per share from continuing operations of $0.57 in the second quarter of 2017. GAAP revenue for the quarter was $703.4 million, as compared to $547.0 million in the second quarter of 2017. GAAP operating income from continuing operations for the quarter was $88.1 million, as compared to $74.2 million in the second quarter of 2017. GAAP operating profit margin was 12.5% as a percentage of revenue.

Adjusted earnings per share from continuing operations for the quarter was $0.91, as compared to $0.67 in the second quarter of 2017. Adjusted revenue for the quarter was $703.6 million, as compared to $547.1 million in the second quarter of 2017. Adjusted operating income from continuing operations for the quarter was $138.3 million, as compared to $97.8 million for the same period a year ago. Adjusted operating profit margin was 19.7% as a percentage of adjusted revenue.

Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.

“We saw continued momentum in the business as both segments experienced double-digit organic revenue growth in the second quarter,” said Robert Friel, chairman and chief executive officer of PerkinElmer.  “Our focus on bringing innovative new product offerings to market, while targeting attractive end markets where our capabilities are well differentiated, continues to drive solid revenue and adjusted earnings growth.  As a result, we are once again raising our full year organic revenue outlook and adjusted earnings per share guidance.”

Financial Overview by Reporting Segment for the Second Quarter of 2018

Discovery & Analytical Solutions

  • Revenue was $430.6 million, as compared to $383.1 million for the second quarter of 2017. Reported revenue increased 12% and organic revenue increased 10%.
  • Operating income from continuing operations was $64.7 million, as compared to $51.1 million for the comparable prior period.
  • Adjusted operating income was $76.4 million, as compared to $63.6 million in the second quarter of 2017.

Diagnostics

  • Revenue was $272.7 million, as compared to $163.8 million for the second quarter of 2017. Reported revenue increased 66% and organic revenue increased 10%.
  • Operating income from continuing operations was $38.8 million, as compared to $36.9 million for the comparable prior period.
  • Adjusted operating income was $77.2 million, as compared to $48.1 million in the second quarter of 2017.

Raises Financial Guidance – Full Year 2018

For the full year 2018, the Company previously forecast GAAP earnings per share from continuing operations of $2.25 and, on a non-GAAP basis, adjusted earnings per share of $3.60. The Company now forecasts GAAP earnings per share from continuing operations of $2.39, and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share of $3.65.

Conference Call Information

The Company will discuss its second quarter results and its outlook for business trends in a conference call on August 1, 2018 at 5:00 p.m. Eastern Time. To access the call, please dial (541) 797-2422 prior to the scheduled conference call time and provide the access code 6379206.

A live audio webcast of the call will be available on the Investor section of the Company’s Web site, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary software. An archived version of the webcast will be posted on the Company’s Web site for a two week period beginning approximately two hours after the call.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses such as EUROIMMUN and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) the United Kingdom’s intention to withdraw from the European Union; (21) our ability to realize the full value of our intangible assets; (22) significant fluctuations in our stock price; (23) reduction or elimination of dividends on our common stock; and (24) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

                           

 PerkinElmer, Inc. and Subsidiaries

 CONDENSED CONSOLIDATED INCOME STATEMENTS

                           
       

Three Months Ended

     

Six Months Ended

(In thousands, except per share data)      

July 1, 2018

   

July 2, 2017

       

July 1, 2018

   

July 2, 2017

                                 
                                 
Revenue       $ 703,362       $ 546,962           $ 1,347,334         $ 1,061,077  
                                 
Cost of revenue         363,222         289,360             714,972           563,719  
Selling, general and administrative expenses         204,880         149,859             404,605           296,867  
Research and development expenses         47,196         33,560             93,180           66,846  
Restructuring and contract termination charges, net         -         -             6,578           9,651  
                                 
Operating income from continuing operations         88,064         74,183             127,999           123,994  
                                 
Interest income         (173 )       (490 )           (438 )         (710 )
Interest expense         16,411         10,672             34,061           21,536  
Loss on disposition of businesses and assets, net         -         301             -           301  
Other expense (income), net         118         (7,092 )           (5,837 )         (7,908 )
                                 
Income from continuing operations, before income taxes         71,708         70,792             100,213           110,775  
                                 
Provision for income taxes         7,035         8,066             9,505           11,987  
                                 
Income from continuing operations         64,673         62,726             90,708           98,788  
                                 
(Loss) income from discontinued operations, before income taxes         -         (3,109 )           -           650  
(Loss) gain on disposition of discontinued operations, before income taxes         (551 )       180,377             (551 )         180,377  
Provision for income taxes on discontinued operations and dispositions         59         35,925             70           37,143  
                                 
(Loss) gain from discontinued operations and dispositions         (610 )       141,343             (621 )         143,884  
                                 
Net income       $ 64,063       $ 204,069           $ 90,087         $ 242,672  
                                 
                                 
Diluted earnings per share:                                
Income from continuing operations       $ 0.58       $ 0.57           $ 0.81         $ 0.89  
                                 
(Loss) gain from discontinued operations and dispositions         (0.01 )       1.28             (0.01 )         1.30  
                                 
Net income       $ 0.57       $ 1.84           $ 0.81         $ 2.20  
                                 
                                 
Weighted average diluted shares of common stock outstanding         111,452         110,762             111,391           110,484  
                                 
                                 
ABOVE PREPARED IN ACCORDANCE WITH GAAP
                                 
         
Additional Supplemental Information (1):                                
(per share, continuing operations)                                
                                 
GAAP EPS from continuing operations       $ 0.58       $ 0.57           $ 0.81         $ 0.89  
Amortization of intangible assets         0.29         0.16             0.59           0.31  
Purchase accounting adjustments         0.14         0.02             0.23           0.05  
Significant litigation matters         (0.00 )       -             0.04           -  
Acquisition and divestiture-related costs         0.02         (0.02 )           0.03           0.01  
Disposition of businesses and assets, net         -         0.00             -           0.00  
Mark to market on postretirement benefits         -         (0.00 )           -           (0.00 )
Restructuring and contract termination charges, net         -         -             0.06           0.09  
Tax on above items         (0.12 )       (0.06 )           (0.24 )         (0.14 )
Impact of tax act         -         -             0.01           -  
Adjusted EPS       $ 0.91       $ 0.67           $ 1.54         $ 1.21  
                                                 

 

                                       
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
                                       
                                       
                                       
             

Three Months Ended

     

Six Months Ended

(In thousands, except percentages)      

July 1, 2018

     

July 2, 2017

     

July 1, 2018

     

July 2, 2017

                                       
                                       
DAS     Reported revenue     $ 430,628       $ 383,128       $ 827,153       $ 744,888  
                                       
      Reported operating income from continued operations       64,665         51,124         100,862         81,346  
      OP%       15.0 %       13.3 %       12.2 %       10.9 %
      Amortization of intangible assets       11,472         12,377         23,183         24,627  
      Purchase accounting adjustments       15         16         30         32  
      Acquisition and divestiture-related expenses       33         110         71         348  
      Significant litigation matters       232         -         4,417         -  
      Restructuring and contract termination charges, net       -         -         5,676         7,987  
      Adjusted operating income       76,417         63,627         134,239         114,340  
      Adjusted OP%       17.7 %       16.6 %       16.2 %       15.3 %
                                       
Diagnostics     Reported revenue       272,734         163,834         520,181         316,189  
      Purchase accounting adjustments       188         186         375         371  
      Adjusted Revenue       272,922         164,020         520,556         316,560  
                                       
      Reported operating income from continued operations       38,780         36,947         57,174         69,663  
      OP%       14.2 %       22.6 %       11.0 %       22.0 %
      Amortization of intangible assets       21,045         5,161         42,234         9,957  
      Purchase accounting adjustments       16,103         2,362         25,631         5,549  
      Acquisition and divestiture-related expenses       1,616         3,593         4,151         5,951  
      Significant litigation matters       (322 )       -         (172 )       -  
      Restructuring and contract termination charges, net       -         -         902         1,664  
      Adjusted operating income       77,222         48,063         129,920         92,784  
      Adjusted OP%       28.3 %       29.3 %       25.0 %       29.3 %
                                       
Corporate     Reported operating loss       (15,381 )       (13,888 )       (30,037 )       (27,015 )
                                       
Continuing Operations     Reported revenue     $ 703,362       $ 546,962       $ 1,347,334       $ 1,061,077  
      Purchase accounting adjustments       188         186         375         371  
      Adjusted Revenue       703,550         547,148         1,347,709         1,061,448  
                                       
      Reported operating income from continued operations       88,064         74,183         127,999         123,994  
      OP%       12.5 %       13.6 %       9.5 %       11.7 %
      Amortization of intangible assets       32,517         17,538         65,417         34,584  
      Purchase accounting adjustments       16,118         2,378         25,661         5,581  
      Acquisition and divestiture-related expenses       1,649         3,703         4,222         6,299  
      Significant litigation matters       (90 )       -         4,245         -  
      Restructuring and contract termination charges, net       -         -         6,578         9,651  
      Adjusted operating income     $ 138,258       $ 97,802       $ 234,122       $ 180,109  
      Adjusted OP%       19.7 %       17.9 %       17.4 %       17.0 %
                                       
                                       

REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP

 

                 
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
                 
                 
                 
(In thousands)      

July 1, 2018

     

December 31, 2017

                 
Current assets:                
Cash and cash equivalents       $ 163,392         $ 202,134  
Accounts receivable, net         564,041           552,304  
Inventories, net         366,961           351,675  
Other current assets         108,019           93,842  
Total current assets         1,202,413           1,199,955  
                 
Property, plant and equipment:                
At cost         706,566           630,919  
Accumulated depreciation         (402,028 )         (332,853 )
Property, plant and equipment, net         304,538           298,066  
Intangible assets, net         1,270,867           1,346,940  
Goodwill         2,940,825           3,002,198  
Other assets, net         239,135           244,304  
Total assets       $ 5,957,778         $ 6,091,463  
                 
Current liabilities:                
Current portion of long-term debt       $ 17,315         $ 217,306  
Accounts payable         197,128           222,093  
Accrued restructuring and contract termination charges         7,443           8,759  
Accrued expenses and other current liabilities         488,642           500,642  
Current liabilities of discontinued operations         2,165           2,102  
Total current liabilities         712,693           950,902  
                 
Long-term debt         1,983,953           1,788,803  
Long-term liabilities         743,955           848,570  
Total liabilities         3,440,601           3,588,275  
                 
Total stockholders' equity         2,517,177           2,503,188  
Total liabilities and stockholders' equity       $ 5,957,778         $ 6,091,463  
                 
                 
PREPARED IN ACCORDANCE WITH GAAP
 

 

                             
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
                             
                             
       

Three Months Ended

     

Six Months Ended

       

July 1, 2018

   

July 2, 2017

     

July 1, 2018

   

July 2, 2017

        (In thousands)       (In thousands)
                             
Operating activities:                            
Net income       $ 64,063       $ 204,069         $ 90,087       $ 242,672  
Loss (gain) from discontinued operations and dispositions, net of income taxes         610         (141,343 )         621         (143,884 )
Income from continuing operations         64,673         62,726           90,708         98,788  
Adjustments to reconcile income from continuing operations                            
to net cash provided by continuing operations:                            
Stock-based compensation         6,816         6,840           12,148         11,767  
Restructuring and contract termination charges, net         -         -           6,578         9,651  
Depreciation and amortization         43,772         24,758           88,225         49,505  
Change in fair value of contingent consideration         6,948         98           7,065         909  
Amortization of deferred debt financing costs and accretion of discounts         904         646           1,519         1,231  
Losses (gains) on disposition of businesses and assets, net         -         301           -         301  
Amortization of acquired inventory revaluation         8,952         2,064           18,160         4,240  
Changes in assets and liabilities which provided (used) cash, excluding                            
effects from companies acquired:                            
Accounts receivable, net         (8,488 )       (19,878 )         (18,768 )       5,215  
Inventories         (17,965 )       (3,075 )         (42,993 )       (9,913 )
Accounts payable         (14,358 )       (6,972 )         (24,384 )       (20,855 )
Accrued expenses and other         (18,268 )       (13,062 )         (79,831 )       (55,193 )
Net cash provided by operating activities of continuing operations         72,986         54,446           58,427         95,646  
Net cash (used in) provided by operating activities of discontinued operations         -         (6,328 )         -         6,207  
Net cash provided by operating activities         72,986         48,118           58,427         101,853  
                             
Investing activities:                            
Capital expenditures         (16,956 )       (5,492 )         (39,608 )       (11,473 )
Proceeds from surrender of life insurance policies         -         45           72         45  
Proceeds from disposition of investments         173         -           173         -  
Activity related to acquisitions and investments, net of cash and cash equivalents acquired         (39,470 )       -           (40,557 )       (123,578 )
Net cash used in investing activities of continuing operations         (56,253 )       (5,447 )         (79,920 )       (135,006 )
Net cash provided by investing activities of discontinued operations         -         277,262           -         276,982  
Net cash (used in) provided by investing activities         (56,253 )       271,815           (79,920 )       141,976  
                             
Financing Activities:                            
Payments on borrowings         (520,000 )       -           (667,000 )       (145,950 )
Proceeds from borrowings         138,000         -           342,000         146,952  
Proceeds from sale of senior debt         369,340         -           369,340         -  
Payments of debt issuance costs         (2,634 )       -           (2,634 )       -  
Settlement of cash flow hedges         3,458         (2,745 )         (32,711 )       (4,314 )
Net payments on other credit facilities         (7,147 )       (291 )         (10,154 )       (577 )
Payments for acquisition-related contingent consideration         -         -           -         (8,940 )
Proceeds from issuance of common stock under stock plans         881         8,596           8,348         13,223  
Purchases of common stock         (95 )       (138 )         (4,649 )       (3,265 )
Dividends paid         (7,744 )       (7,690 )         (15,471 )       (15,363 )
Net cash used in financing activities of continuing operations         (25,941 )       (2,268 )         (12,931 )       (18,234 )
Net cash used in financing activities of discontinued operations         -         (319 )         -         (533 )
Net cash used in financing activities         (25,941 )       (2,587 )         (12,931 )       (18,767 )
                             
Effect of exchange rate changes on cash, cash equivalents, and restricted cash         (8,201 )       8,583           (4,351 )       14,928  
                             
Net decrease in cash, cash equivalents, and restricted cash         (17,409 )       325,929           (38,775 )       239,990  
Cash, cash equivalents, and restricted cash at beginning of period         181,005         290,629           202,371         376,568  
Cash, cash equivalents, and restricted cash at end of period       $ 163,596       $ 616,558         $ 163,596       $ 616,558  
                             
                             
Supplemental disclosure of cash flow information:                            
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:                    
Cash and cash equivalents       $ 163,392         616,308         $ 163,392         616,308  
Restricted cash included in other current assets         204         250           204         250  
Total cash, cash equivalents and restricted cash       $ 163,596       $ 616,558         $ 163,596       $ 616,558  
                             
PREPARED IN ACCORDANCE WITH GAAP

 

                           
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
         
(In millions, except per share data and percentages)       PKI
        Three Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted revenue:                          
Revenue       $ 703.4             $ 547.0        
Purchase accounting adjustments         0.2               0.2        
Adjusted revenue       $ 703.6             $ 547.1        
                           
Adjusted gross margin:                          
Gross margin       $ 340.1       48.4 %     $ 257.6       47.1 %
Amortization of intangible assets         11.6       1.6 %       7.1       1.3 %
Purchase accounting adjustments         9.2       1.3 %       2.3       0.4 %
Adjusted gross margin       $ 360.9       51.3 %     $ 267.0       48.8 %
                           
Adjusted SG&A:                          
SG&A       $ 204.9       29.1 %     $ 149.9       27.4 %
Amortization of intangible assets         (20.9 )     -3.0 %       (10.4 )     -1.9 %
Purchase accounting adjustments         (7.0 )     -1.0 %       (0.1 )     0.0 %
Acquisition and divestiture-related expenses         (1.6 )     -0.2 %       (3.7 )     -0.7 %
Significant litigation matters         0.1       0.0 %       -       0.0 %
Adjusted SG&A       $ 175.5       24.9 %     $ 135.7       24.8 %
                           
Adjusted R&D:                          
R&D       $ 47.2       6.7 %     $ 33.6       6.1 %
Amortization of intangible assets         (0.1 )     0.0 %       (0.1 )     0.0 %
Adjusted R&D       $ 47.1       6.7 %     $ 33.5       6.1 %
                           
Adjusted operating income:                          
Operating income       $ 88.1       12.5 %     $ 74.2       13.6 %
Amortization of intangible assets         32.5       4.6 %       17.5       3.2 %
Purchase accounting adjustments         16.1       2.3 %       2.4       0.4 %
Acquisition and divestiture-related expenses         1.6       0.2 %       3.7       0.7 %
Significant litigation matters         (0.1 )     0.0 %       -       0.0 %
Restructuring and contract termination charges, net         -       0.0 %       -       0.0 %
Adjusted operating income       $ 138.3       19.7 %     $ 97.8       17.9 %
                           
                           
        PKI
        Three Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted EPS:                          
GAAP EPS       $ 0.57             $ 1.84        
Discontinued operations, net of income taxes         (0.01 )             1.28        
GAAP EPS from continuing operations         0.58               0.57        
Amortization of intangible assets         0.29               0.16        
Purchase accounting adjustments         0.14               0.02        
Significant litigation matters         (0.00 )             -        
Acquisition and divestiture-related expenses         0.02               (0.02 )      
Gain on disposition of businesses and assets, net         -               0.00        
Mark to market on postretirement benefits         -               (0.00 )      
Tax on above items         (0.12 )             (0.06 )      
Adjusted EPS       $ 0.91             $ 0.67        
                           
                           
        DAS
        Three Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Revenue       $ 430.6             $ 383.1        
                           
Adjusted operating income:                          
Operating income       $ 64.7       15.0 %     $ 51.1       13.3 %
Amortization of intangible assets         11.5       2.7 %       12.4       3.2 %
Purchase accounting adjustments         0.0       0.0 %       0.0       0.0 %
Acquisition and divestiture-related expenses         0.0       0.0 %       0.1       0.0 %
Significant litigation matters         0.2       0.1 %       -       0.0 %
Adjusted operating income       $ 76.4       17.7 %     $ 63.6       16.6 %
                           
                           
        Diagnostics
        Three Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted revenue:                          
Revenue       $ 272.7             $ 163.8        
Purchase accounting adjustments         0.2               0.2        
Adjusted revenue       $ 272.9             $ 164.0        
                           
Adjusted operating income:                          
Operating income       $ 38.8       14.2 %     $ 36.9       22.6 %
Amortization of intangible assets         21.0       7.7 %       5.2       3.2 %
Purchase accounting adjustments         16.1       5.9 %       2.4       1.4 %
Acquisition and divestiture-related expenses         1.6       0.6 %       3.6       2.2 %
Significant litigation matters         (0.3 )     -0.1 %       -       0.0 %
Adjusted operating income       $ 77.2       28.3 %     $ 48.1       29.3 %
                           
                           
(1) amounts may not sum due to rounding                          

 

                           
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
         
(In millions, except per share data and percentages)       PKI
        Six Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted revenue:                          
Revenue       $ 1,347.3             $ 1,061.1        
Purchase accounting adjustments         0.4               0.4        
Adjusted revenue       $ 1,347.7             $ 1,061.4        
                           
Adjusted gross margin:                          
Gross margin       $ 632.4       46.9 %     $ 497.4       46.9 %
Amortization of intangible assets         23.3       1.7 %       14.2       1.3 %
Purchase accounting adjustments         18.6       1.4 %       4.6       0.4 %
Adjusted gross margin       $ 674.2       50.0 %     $ 516.2       48.6 %
                           
Adjusted SG&A:                          
SG&A       $ 404.6       30.0 %     $ 296.9       28.0 %
Amortization of intangible assets         (42.0 )     -3.1 %       (20.2 )     -1.9 %
Purchase accounting adjustments         (7.1 )     -0.5 %       (0.9 )     -0.1 %
Acquisition and divestiture-related expenses         (4.2 )     -0.3 %       (6.3 )     -0.6 %
Significant litigation matters         (4.2 )     -0.3 %       -       0.0 %
Adjusted SG&A       $ 347.0       25.8 %     $ 269.4       25.4 %
                           
Adjusted R&D:                          
R&D       $ 93.2       6.9 %     $ 66.8       6.3 %
Amortization of intangible assets         (0.2 )     0.0 %       (0.2 )     0.0 %
Adjusted R&D       $ 93.0       6.9 %     $ 66.7       6.3 %
                           
Adjusted operating income:                          
Operating income       $ 128.0       9.5 %     $ 124.0       11.7 %
Amortization of intangible assets         65.4       4.9 %       34.6       3.3 %
Purchase accounting adjustments         25.7       1.9 %       5.6       0.5 %
Acquisition and divestiture-related expenses         4.2       0.3 %       6.3       0.6 %
Significant litigation matters         4.2       0.3 %       -       0.0 %
Restructuring and contract termination charges, net         6.6       0.5 %       9.7       0.9 %
Adjusted operating income       $ 234.1       17.4 %     $ 180.1       17.0 %
                           
                           
        PKI
        Six Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted EPS:                          
GAAP EPS       $ 0.81             $ 2.20        
Discontinued operations         (0.01 )             1.30        
GAAP EPS from continuing operations         0.81               0.89        
Amortization of intangible assets         0.59               0.31        
Purchase accounting adjustments         0.23               0.05        
Significant litigation matters         0.04               -        
Acquisition and divestiture-related expenses         0.03               0.01        
Gain on disposition of businesses and assets, net         -               0.00        
Mark to market on postretirement benefits         -               (0.00 )      
Restructuring and contract termination charges, net         0.06               0.09        
Tax on above items         (0.24 )             (0.14 )      
Impact of tax act         0.01               -        
Adjusted EPS       $ 1.54             $ 1.21        
         
         
        PKI
                    Twelve Months Ended
                   

December 30, 2018

Adjusted EPS:                   Projected
GAAP EPS from continuing operations                   $ 2.39        
Amortization of intangible assets                     1.20        
Purchase accounting adjustments                     0.31        
Significant litigation matters                     0.04        
Acquisition and divestiture-related expenses                     0.06        
Restructuring and contract termination charges, net                     0.06        
Tax on above items                     (0.42 )      
Impact of tax act                     0.01        
Adjusted EPS                   $ 3.65        
                           
                           
        DAS
        Six Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Revenue       $ 827.2             $ 744.9        
                           
Adjusted operating income:                          
Operating income       $ 100.9       12.2 %     $ 81.3       10.9 %
Amortization of intangible assets         23.2       2.8 %       24.6       3.3 %
Purchase accounting adjustments         0.0       0.0 %       0.0       0.0 %
Acquisition and divestiture-related expenses         0.1       0.0 %       0.3       0.0 %
Significant litigation matters         4.4       0.5 %       -       0.0 %
Restructuring and contract termination charges, net         5.7       0.7 %       8.0       1.1 %
Adjusted operating income       $ 134.2       16.2 %     $ 114.3       15.3 %
                           
         
        Diagnostics
        Six Months Ended
       

July 1, 2018

         

July 2, 2017

     
                           
Adjusted revenue:                          
Revenue       $ 520.2             $ 316.2        
Purchase accounting adjustments         0.4               0.4        
Adjusted revenue       $ 520.6             $ 316.6        
                           
Adjusted operating income:                          
Operating income       $ 57.2       11.0 %     $ 69.7       22.0 %
Amortization of intangible assets         42.2       8.1 %       10.0       3.1 %
Purchase accounting adjustments         25.6       4.9 %       5.5       1.8 %
Acquisition and divestiture-related expenses         4.2       0.8 %       6.0       1.9 %
Significant litigation matters         (0.2 )     0.0 %       -       0.0 %
Restructuring and contract termination charges, net         0.9       0.2 %       1.7       0.5 %
Adjusted operating income       $ 129.9       25.0 %     $ 92.8       29.3 %
                           
                           
(1) amounts may not sum due to rounding                          

 

         
PerkinElmer, Inc. and Subsidiaries        
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES        
         
         
       

PKI

        Three Months Ended
       

July 1, 2018

Core Organic revenue growth:

       
Reported revenue growth       29%
Less: effect of foreign exchange rates       3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses       16%

Core Organic revenue growth

      10%
         
         
       

DAS

        Three Months Ended
       

July 1, 2018

Organic revenue growth:        
Reported revenue growth       12%
Less: effect of foreign exchange rates       2%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses       0%
Organic revenue growth       10%
         
         
        Diagnostics
        Three Months Ended
       

July 1, 2018

Organic revenue growth:        
Reported revenue growth       66%
Less: effect of foreign exchange rates       3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses       53%
Organic revenue growth       10%

 

Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

We use the term “adjusted revenue” to refer to GAAP revenue, including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term “adjusted revenue growth” to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year.

We use the term “organic revenue” to refer to GAAP revenue, excluding the effect of foreign currency changes and including acquisitions growth from the comparable prior period, and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We also exclude the impact of sales from divested businesses by deducting the effects of divested business revenue from the current and prior periods. We use the related term “organic revenue growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.

We use the term “core organic revenue” to refer to GAAP revenue excluding Euroimmun, excluding the effect of foreign currency changes and including acquisitions growth from the comparable prior period, and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We also exclude the impact of sales from divested businesses by deducting the effects of divested business revenue from the current and prior periods. We use the related term “core organic revenue growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.

We use the term “adjusted gross margin” to refer to GAAP gross margin, excluding amortization of intangible assets and inventory fair value adjustments related to business acquisitions, and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term “adjusted gross margin percentage” to refer to adjusted gross margin as a percentage of adjusted revenue.

We use the term “adjusted SG&A expense” to refer to GAAP SG&A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and significant environmental charges. We use the related term “adjusted SG&A percentage” to refer to adjusted SG&A expense as a percentage of adjusted revenue.

We use the term “adjusted R&D expense” to refer to GAAP R&D expense, excluding amortization of intangible assets. We use the related term “adjusted R&D percentage” to refer to adjusted R&D expense as a percentage of adjusted revenue.

We use the term “adjusted operating income,” to refer to GAAP operating income, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding amortization of intangible assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters, significant environmental charges, and restructuring and contract termination charges. We use the related terms “adjusted operating profit percentage,” “adjusted operating profit margin,” or “adjusted operating margin” to refer to adjusted operating income as a percentage of adjusted revenue.

We use the term “adjusted earnings per share,” or “adjusted EPS,” to refer to GAAP earnings per share, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding discontinued operations, amortization of intangible assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters, significant environmental charges, disposition of businesses and assets, net, and restructuring and contract termination charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We also adjust for any tax impact related to the above items.

Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:

  • Amortization of intangible assets— purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
  • Revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules—accounting rules require us to account for the fair value of revenue from contracts assumed in connection with our acquisitions. As a result, our GAAP results reflect the fair value of those revenues, which is not the same as the revenue that otherwise would have been recorded by the acquired entity. We include such revenue in our non-GAAP measures because we believe the fair value of such revenue does not accurately reflect the performance of our ongoing operations for the period in which such revenue is recorded.
  • Other purchase accounting adjustments—accounting rules require us to adjust various balance sheet accounts, including inventory and deferred rent balances to fair value at the time of the acquisition. As a result, the expenses for these items in our GAAP results are not the same as what would have been recorded by the acquired entity. Accounting rules also require us to estimate the fair value of contingent consideration at the time of the acquisition, and any subsequent changes to the estimate or payment of the contingent consideration and purchase accounting adjustments are charged to expense or income. We exclude the impact of any changes to contingent consideration from our non-GAAP measures because we believe these expenses or benefits do not accurately reflect the performance of our ongoing operations for the period in which such expenses or benefits are recorded.
  • Acquisition and divestiture-related expenses—we incur legal, due diligence, stay bonuses, interest expense, foreign exchange gains and losses, significant acquisition integration expenses and other costs related to acquisitions and divestitures. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Restructuring and contract termination charges—restructuring and contract termination expenses consist of employee severance and other exit costs as well as the cost of terminating certain lease agreements or contracts. Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported.
  • Adjustments for mark-to-market accounting on post-retirement benefits—we exclude adjustments for mark-to-market accounting on post-retirement benefits, and therefore only our projected costs are used to calculate our non-GAAP measures. We exclude these adjustments because they do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure.
  • Significant litigation matters—we incur expenses related to significant litigation matters. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Significant environmental charges—we incur expenses related to significant environmental charges. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Disposition of businesses and assets, net—we exclude the impact of gains or losses from the disposition of businesses and assets from our adjusted earnings per share. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported.
  • Impact of foreign currency changes on the current period—we exclude the impact of foreign currency from these measures by using the prior period’s foreign currency exchange rates for the current period because foreign currency exchange rates are subject to volatility and can obscure underlying trends.

The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board’s Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions and divestitures, significant litigation matters, significant environmental charges, adjustments for mark-to-market accounting on post-retirement benefits, disposition of businesses and assets, net, restructuring and contract termination charges, and the revenue from contracts acquired with various acquisitions is calculated based on operational results and applicable jurisdictional law, which contemplates tax rates currently in effect to determine our tax provision. The tax effect for the impact from foreign currency exchange rates on the current period is calculated based on the average rate currently in effect to determine our tax provision.

The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures by which to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.

Each of the non-GAAP financial measures listed above is also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.

 

Contacts

PerkinElmer, Inc.
Investor Relations:
Tommy J. Thomas, CPA, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
Fara Goldberg, 781-663-5699
fara.goldberg@perkinelmer.com

 

 
 

Source: PerkinElmer, Inc.

Back to news